Body radiation exposure in breast cancer radiotherapy: Impact of breast IMRT and virtual wedge comipensation techniques

被引:49
作者
Woo, Tony C. S.
Pignol, Jean-Philippe
Rakovitch, Eileen
Vu, Toni
Hicks, Deanna
O'Brien, Peter
Pritchard, Kathleen
机构
[1] Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Radiat Oncol, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med Phys, Toronto, ON M4N 3M5, Canada
[3] Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med Oncol, Toronto, ON M4N 3M5, Canada
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 65卷 / 01期
基金
加拿大健康研究院;
关键词
breast neoplasms; combined modality therapy; anthracyclines; radiotherapy; leukemia; IMRT;
D O I
10.1016/j.ijrobp.2005.11.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Recent reports demonstrate a dramatically increased rate of secondary leukemia for breast cancer patients receiving adjuvant high-dose anthracycline and radiotherapy, and that radiation is an independent factor for the development of leukemia. This study aimed to evaluate the radiation body exposure during breast radiotherapy and to characterize the factors associated with an increased exposure. Patients and Methods: In a prospective cohort of 120 women, radiation measurements were taken from four sites on the body at the time of adjuvant breast radiotherapy. Multiple regression analysis was performed to analyze patient and treatment factors associated with the amount of scattered radiation. Results: For standard 50 Gy breast radiotherapy, the minimal dose received by abdominal organs is on average 0.45 Gy, ranging from 0.06 to 1.55 Gy. The use of physical wedges as a compensation technique was the most significant factor associated with increased scattered dose (p < 0.001), resulting in approximately three times more exposure compared with breast intensity-modulated radiation therapy (IMRT) and dynamic wedge. Conclusions: The amount of radiation that is scattered to a patient's body is consistent with exposure reported to be associated with excess of leukemia. In accordance with the As Low As Reasonably Achievable (ALARA) principle, we recommend using breast IMRT or virtual wedging for the radiotherapy of breast cancer receiving high-dose anthracycline chemotherapy. (c) 2006 Elsevier Inc.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 37 条
[1]  
ABE O, 1995, NEW ENGL J MED, V333, P1444
[2]   Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. [J].
Bartelink, H ;
Horiot, J ;
Poortmans, P ;
Struikmans, H ;
Van den Bogaert, W ;
Barillot, I ;
Fourquet, A ;
Borger, J ;
Jager, J ;
Hoogenraad, W ;
Collette, L ;
Pierart, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) :1378-1387
[3]   Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer:: 10-year follow-up results of The French Adjuvant Study Group 05 randomized trial [J].
Bonneterre, J ;
Roché, H ;
Kerbrat, P ;
Brémond, A ;
Fumoleau, P ;
Namer, M ;
Goudier, MJ ;
Schraub, S ;
Fargeot, P ;
Chapelle-Marcillac, I .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2686-2693
[4]   A comparison of different intensity modulation treatment techniques for tangential breast irradiation [J].
Chang, SX ;
Deschesne, KM ;
Cullip, TJ ;
Parker, SA ;
Earnhart, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (05) :1305-1314
[5]   Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: A report from the National Cancer Institute of Canada Clinical Trials Group [J].
Crump, M ;
Tu, DS ;
Shepherd, L ;
Levine, M ;
Bramwell, V ;
Pritchard, K .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) :3066-3071
[6]   RISK OF LEUKEMIA AFTER CHEMOTHERAPY AND RADIATION TREATMENT FOR BREAST-CANCER [J].
CURTIS, RE ;
BOICE, JD ;
STOVALL, M ;
BERNSTEIN, L ;
GREENBERG, RS ;
FLANNERY, JT ;
SCHWARTZ, AG ;
WEYER, P ;
MOLONEY, WC ;
HOOVER, RN .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (26) :1745-1751
[7]   CAUSE-SPECIFIC MORTALITY IN LONG-TERM SURVIVORS OF BREAST-CANCER WHO PARTICIPATED IN TRIALS OF RADIOTHERAPY [J].
CUZICK, J ;
STEWART, H ;
RUTQVIST, L ;
HOUGHTON, J ;
EDWARDS, R ;
REDMOND, C ;
PETO, R ;
BAUM, M ;
FISHER, B ;
HOST, H ;
LYTHGOE, J ;
RIBEIRO, G ;
SCHEURLEN, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :447-453
[8]   Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation [J].
Delwail, V ;
Jais, JP ;
Colonna, P ;
Andrieu, JM .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (01) :189-194
[9]   Execution of a single-isocenter three-field technique, using a multileaf collimator or tray-mounted cerrobend blocks: Effect on treatment time [J].
DeMeerleer, GO ;
Derie, CMT ;
Vakaet, L ;
Fortan, LG ;
Mersseman, BKG ;
DeNeve, WJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (01) :255-259
[10]   Validation of a new virtual wedge model [J].
Desobry, GE ;
Waldron, TJ ;
Das, IJ .
MEDICAL PHYSICS, 1998, 25 (01) :71-72